Hikma Pharmaceuticals

Hikma extends recall of pain drug, reports adverse event

So far, the company has received one report of an adverse event stemming from the "potential presence" of a sedative inside the pain med's packaging.

Zoey Becker Jul 23, 2024 1:12pm

Gavel with scales of justice in background

Amarin, after stock crash and layoffs, revives patent lawsuit

Jun 26, 2024 1:01pm

layoffs job losses cuts workforce reduction

Xellia plots 247 layoffs on the heels of Ohio plant sale

Jun 24, 2024 1:52pm

Hikma acquires some Xellia US assets for up to $185M

Jun 20, 2024 8:57am

Amarin Vascepa box

Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

Mar 29, 2024 1:10pm

Pfizer

Pfizer's massive North Carolina plant hit by tornado

Jul 20, 2023 10:10am